As a European patient-led advocacy and action organisation, we strive to involve patients with asthma, allergy and COPD in European decisions that influence their health. Through our members, we advocate and try to ensure that the right and access of people with asthma, allergy and COPD to best quality care, to participate in their care, have a safe environment of care and to live uncompromised lives is guaranteed by EU decision-makers.
- EFA fosters dialogue, exchange and collaboration among its network of national patients’ associations to help people with allergy, asthma and COPD understand, be informed about and continuously take part in the EU legislative process through news, briefings, educational tools, position papers, responses to consultations or advocacy materials.
- EFA represents patients with allergy, asthma and COPD at high-level fora, such as the European Medicines Agency Patients’ and Consumers’ Working Party.
- EFA regularly organises high level events providing opportunities for stakeholders to come together with a patient-centered agenda on issues under discussion, raising awareness and giving visibility to topics that are crucial for people with allergy, asthma and COPD.
- EFA develops and promotes long term partnership with health professionals and scientists, industry and third sector organisations active in health, consumption and environment matters to ensure a holistic approach to policy changes affecting patients’ health.